Loading...
By Kelly Young
Edited by Jaye Elizabeth Hefner, MD
Patients presenting with acute respiratory tract infections are commonly treated with systemic corticosteroids — even though guidelines don't recommend this practice — according to a research letter in JAMA Internal Medicine.
Researchers retrospectively studied nearly 40,000 adults with an outpatient diagnosis of acute respiratory infection across the U.S. and in Louisiana in particular. Nationally, 11% of patients were prescribed steroids. In Louisiana, 23% of these primary care encounters resulted in a steroid injection. In both cohorts, the odds of receiving steroids were higher for patients with a visit diagnosis of bronchitis or a history of chronic obstructive pulmonary disease.
The authors highlight the adverse effects associated with short-term steroid use and the lack of efficacy in sinusitis and bronchitis.
Comment
LINK(S):
JAMA Internal Medicine research letter (Subscription required)
Background: NEJM Journal Watch General Medicine coverage of oral corticosteroids for probable bronchitis (Your NEJM Journal Watch subscription required)
Background: NEJM Journal Watch General Medicine coverage of adverse effects of short-term steroid use (Free)